BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 34587481)

  • 1. Enhanced eosinophil-mediated inflammation associated with antibody and complement-dependent pneumonic insults in critical COVID-19.
    Kim DM; Kim Y; Seo JW; Lee J; Park U; Ha NY; Koh J; Park H; Lee JW; Ro HJ; Yun NR; Kim DY; Yoon SH; Na YS; Moon DS; Lim SC; Kim CM; Jeon K; Kang JG; Jang NY; Jeong H; Kim J; Cheon S; Sohn KM; Moon JY; Kym S; Han SR; Lee MS; Kim HJ; Park WY; Choi JY; Shin HW; Kim HY; Cho CH; Jeon YK; Kim YS; Cho NH
    Cell Rep; 2021 Oct; 37(1):109798. PubMed ID: 34587481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation.
    Jarlhelt I; Nielsen SK; Jahn CXH; Hansen CB; Pérez-Alós L; Rosbjerg A; Bayarri-Olmos R; Skjoedt MO; Garred P
    Front Immunol; 2021; 12():767981. PubMed ID: 34804055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COVID-19 Severity Is Associated with Differential Antibody Fc-Mediated Innate Immune Functions.
    Adeniji OS; Giron LB; Purwar M; Zilberstein NF; Kulkarni AJ; Shaikh MW; Balk RA; Moy JN; Forsyth CB; Liu Q; Dweep H; Kossenkov A; Weiner DB; Keshavarzian A; Landay A; Abdel-Mohsen M
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody.
    Gebremeskel S; Schanin J; Coyle KM; Butuci M; Luu T; Brock EC; Xu A; Wong A; Leung J; Korver W; Morin RD; Schleimer RP; Bochner BS; Youngblood BA
    Front Immunol; 2021; 12():650331. PubMed ID: 33777047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-Dependent Enhancement and the Critical Pattern of COVID-19: Possibilities and Considerations.
    Farshadpour F; Taherkhani R
    Med Princ Pract; 2021; 30(5):422-429. PubMed ID: 33882487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.
    Wang B; Wang L; Kong X; Geng J; Xiao D; Ma C; Jiang XM; Wang PH
    J Med Virol; 2020 Sep; 92(9):1684-1689. PubMed ID: 32343415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-Specific Immunopathology in Fatal COVID-19.
    Dorward DA; Russell CD; Um IH; Elshani M; Armstrong SD; Penrice-Randal R; Millar T; Lerpiniere CEB; Tagliavini G; Hartley CS; Randle NP; Gachanja NN; Potey PMD; Dong X; Anderson AM; Campbell VL; Duguid AJ; Al Qsous W; BouHaidar R; Baillie JK; Dhaliwal K; Wallace WA; Bellamy COC; Prost S; Smith C; Hiscox JA; Harrison DJ; Lucas CD
    Am J Respir Crit Care Med; 2021 Jan; 203(2):192-201. PubMed ID: 33217246
    [No Abstract]   [Full Text] [Related]  

  • 8. Low Innate Immunity and Lagged Adaptive Immune Response in the Re-Tested Viral RNA Positivity of a COVID-19 Patient.
    Lai C; Liu X; Yan Q; Lv H; Zhou L; Hu L; Cai Y; Wang G; Chen Y; Chai R; Liu Z; Xu Y; Huang W; Xiao F; Hu L; Li Y; Huang J; Zhou Q; Li L; Peng T; Zhang H; Zhang Z; Chen L; Chen C; Ji T
    Front Immunol; 2021; 12():664619. PubMed ID: 34305895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Collision of Meta-Inflammation and SARS-CoV-2 Pandemic Infection.
    Huizinga GP; Singer BH; Singer K
    Endocrinology; 2020 Nov; 161(11):. PubMed ID: 32880654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunoglobulin, IgG Fc receptor and complement triangle in autoimmune diseases.
    Karsten CM; Köhl J
    Immunobiology; 2012 Nov; 217(11):1067-79. PubMed ID: 22964232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Involvement of the complement cascade in severe forms of COVID-19].
    Chouaki Benmansour N; Carvelli J; Vivier É
    Med Sci (Paris); 2021 Apr; 37(4):333-341. PubMed ID: 33835019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity.
    Vono M; Huttner A; Lemeille S; Martinez-Murillo P; Meyer B; Baggio S; Sharma S; Thiriard A; Marchant A; Godeke GJ; Reusken C; Alvarez C; Perez-Rodriguez F; Eckerle I; Kaiser L; Loevy N; Eberhardt CS; Blanchard-Rohner G; Siegrist CA; Didierlaurent AM
    Cell Rep; 2021 Oct; 37(1):109773. PubMed ID: 34587479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lectin Pathway Mediates Complement Activation by SARS-CoV-2 Proteins.
    Ali YM; Ferrari M; Lynch NJ; Yaseen S; Dudler T; Gragerov S; Demopulos G; Heeney JL; Schwaeble WJ
    Front Immunol; 2021; 12():714511. PubMed ID: 34290717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity.
    Nielsen SS; Vibholm LK; Monrad I; Olesen R; Frattari GS; Pahus MH; Højen JF; Gunst JD; Erikstrup C; Holleufer A; Hartmann R; Østergaard L; Søgaard OS; Schleimann MH; Tolstrup M
    EBioMedicine; 2021 Jun; 68():103410. PubMed ID: 34098342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin G Immune Complexes May Contribute to Neutrophil Activation in the Course of Severe Coronavirus Disease 2019.
    Mazzitelli I; Bleichmar L; Ludueña MG; Pisarevsky A; Labato M; Chiaradia V; Finocchieto P; Paulin F; Hormanstorfer M; Baretto MC; Adanza SP; Parodi MN; Ragusa M; Melucci C; Díaz FE; Paletta A; Di Diego F; Ceballos A; Geffner J
    J Infect Dis; 2021 Aug; 224(4):575-585. PubMed ID: 34398243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early humoral defence: Contributing to confining COVID-19 to conducting airways?
    Persson C
    Scand J Immunol; 2021 Jun; 93(6):e13024. PubMed ID: 33523532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement Factors in COVID-19 Therapeutics and Vaccines.
    Kurtovic L; Beeson JG
    Trends Immunol; 2021 Feb; 42(2):94-103. PubMed ID: 33402318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of classical and alternative complement pathways in the pathogenesis of lung injury in COVID-19.
    Satyam A; Tsokos MG; Brook OR; Hecht JL; Moulton VR; Tsokos GC
    Clin Immunol; 2021 May; 226():108716. PubMed ID: 33774179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to COVID-19 infection: a double-edged sword.
    Saad N; Moussa S
    Immunol Med; 2021 Sep; 44(3):187-196. PubMed ID: 33444511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal Profiling of Antibody Response in Patients With COVID-19 in a Tertiary Care Hospital in Beijing, China.
    Feng X; Yin J; Zhang J; Hu Y; Ouyang Y; Qiao S; Zhao H; Zhang T; Li X; Zhang L; Zhang J; Jin R; Feng Y; Su B
    Front Immunol; 2021; 12():614436. PubMed ID: 33790892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.